Actemra (Tocilizumab) 400 mg/20 mL Concentrate for Solution for Infusion

Actemra is a biologic medication containing Tocilizumab, provided as a concentrated vial for intravenous infusion to manage inflammatory conditions.

EGP 14,160

In Stock

Delivery to governorates within 3-4 working days

Easy returns within 14 days

Specifications

SKU	CT-79
Color	Luscious Blackberry

About the product›

About Actemra (Tocilizumab) 400 mg/20 mL

Actemra, is a specialized prescription-only medicine containing the active ingredient Tocilizumab. It is formulated as a 20 mg/mL concentrate, with each vial containing 400 mg in 20 mL of solution, designed specifically for intravenous infusion.

Therapeutic Use

Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 (IL-6) receptor, effectively reducing inflammation associated with various autoimmune and inflammatory conditions.

Key Product Features

Concentration: 20 mg/mL (Total 400 mg per 20 mL vial).
Administration: Must be prepared as a solution for intravenous infusion.
Presentation: Single vial of 20 mL concentrate.
Manufacturer: Produced by Roche, ensuring pharmaceutical quality and reliability.

This product is a prescription-only medicine intended for use by healthcare professionals. Please keep out of reach of children and follow strict clinical guidelines for preparation and administration.